Breast Cancer

EA1181 / CompassHER2 pCR

Preoperative THP & Postoperative HP in Patients who Achieve a Pathologic Complete Response

Part 1 Component of: The CompassHER2 Trials (COMprehensive use of Pathologic response ASSessment to optimize therapy in HER2 positive breast cancer

Physician and Research Staff Educational Material

This material is intended for promotional use among health care professionals and is NOT intended for use as patient educational material.

Physician Fact Sheet
Schema, eligibility criteria, and treatment details
Study Summary for Physicians
Schema, study objectives, eligibility criteria, and other key information about the study
EA1181 / CompassHER2 pCR Educational Materials
Clinical Trial Home Page
View EA1181 Record on ClinicalTrials.gov
Review Other Active Trials
ECOG-ACRIN Cancer Research Group